These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity. Jiang WW; Fujii H; Shirai T; Mega H; Takagi M Cancer; 2001 Nov; 92(9):2349-56. PubMed ID: 11745290 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia. Maimaiti A; Abudoukeremu K; Tie L; Pan Y; Li X Gene; 2015 Mar; 558(2):271-7. PubMed ID: 25576219 [TBL] [Abstract][Full Text] [Related]
28. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919 [TBL] [Abstract][Full Text] [Related]
29. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia. Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094 [TBL] [Abstract][Full Text] [Related]
30. Implication of TIPE2 Expression on the Malignant Transformation of Oral Leukoplakia. Chen H; Pei M; Shin SW; Moon S; Nam W; Zheng Z Anticancer Res; 2023 Nov; 43(11):4937-4946. PubMed ID: 37909982 [TBL] [Abstract][Full Text] [Related]
31. Flow cytometric analysis of nuclear DNA content in oral leukoplakia. Seoane J; Bascones A; Asenjo JA; García-Pola M; Varela-Centelles PI Clin Otolaryngol Allied Sci; 1998 Apr; 23(2):136-40. PubMed ID: 9597283 [TBL] [Abstract][Full Text] [Related]
32. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression]. Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260 [TBL] [Abstract][Full Text] [Related]
33. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia. Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153 [TBL] [Abstract][Full Text] [Related]
34. Management of oral epithelial dysplasia: a review. Brennan M; Migliorati CA; Lockhart PB; Wray D; Al-Hashimi I; Axéll T; Bruce AJ; Carpenter W; Eisenberg E; Epstein JB; Holmstrup P; Jontell M; Nair R; Sasser H; Schifter M; Silverman B; Thongprasom K; Thornhill M; Warnakulasuriya S; van der Waal I Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S19.e1-12. PubMed ID: 17257863 [TBL] [Abstract][Full Text] [Related]
35. A Novel Mutation in the DNA Binding Domain of NFKB is Associated with Speckled Leukoplakia. Govindarajan GV; Bhanumurthy L; Balasubramanian A; Ramanathan A Asian Pac J Cancer Prev; 2016; 17(7):3627-9. PubMed ID: 27510021 [TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity: a potential tool in management of oral premalignant lesions? Zhang L; Rosin MP J Oral Pathol Med; 2001 Oct; 30(9):513-20. PubMed ID: 11555152 [TBL] [Abstract][Full Text] [Related]
37. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology. Müller S Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637 [TBL] [Abstract][Full Text] [Related]
38. MicroRNAs and their role in the malignant transformation of oral leukoplakia: a scoping review. Niklander S; Guerra D; Contreras F; González-Arriagada W; Marín C Med Oral Patol Oral Cir Bucal; 2022 Jan; 27(1):e77-e84. PubMed ID: 34564679 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic significance of nuclear DNA content and nuclear area in oral hyperplasia, dysplasia, and carcinoma. Kinoshita Y; Inoue S; Honma Y; Shimura K J Oral Maxillofac Surg; 1992 Jul; 50(7):728-33. PubMed ID: 1608003 [TBL] [Abstract][Full Text] [Related]
40. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study. Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]